BANK OF AMERICA CORP /DE/

Bank

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 70858 CHARLOTTE, NC

Back to VNDA Full portfolio

Position in VNDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,301,619

-$24,595 QoQ

Shares Held

212,683

+10.8% QoQ

Ownership

0.352%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 172 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in VNDA Over Time

Shares Held

Position Value (USD)

Derivatives in VNDA

reported options exposure · as of Dec 31, 2020

CallValue

CallShares

PutValue

PutShares

23,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. VNDA ranks #201 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,039,178	$1,509,650,884
2	REGN	Regeneron Pharmaceuticals, Inc.	1,291,053	$805,023,185
3	CYTK	Cytokinetics Inc	4,635,709	$394,916,048
4	ARGX	Argenx SE	400,234	$371,325,094
5	ALNY	Alnylam Pharmaceuticals, Inc.	994,476	$299,367,107
6	JAZZ	Jazz Pharmaceuticals plc	1,136,091	$273,763,844
7	TVTX	Travere Therapeutics, Inc.	4,568,341	$259,527,450
8	RPRX	Royalty Pharma plc	4,149,422	$232,658,090

All Filings in VNDA

Export CSV

37 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,301,619	212,683	+10.8%	Shares	Defined	2026-08-14
2026-03-31	$1,326,214	191,927	+135.7%	Shares	Defined	2026-05-18
2025-12-31	$718,070	81,414	-23.5%	Shares	Defined	2026-02-17
2025-09-30	$531,114	106,436	-28.8%	Shares	Defined	2026-02-03
2025-06-30	$705,502	149,471	+23.0%	Shares	Defined	2025-08-14
2025-03-31	$557,968	121,562	-5.3%	Shares	Defined	2025-05-15
2024-12-31	$614,728	128,336	+28.8%	Shares	Defined	2025-02-14
2024-09-30	$467,485	99,677	+28.8%	Shares	Defined	2024-11-14
2024-06-30	$437,411	77,418	-93.6%	Shares	Defined	2024-08-14
2024-03-31	$4,965,952	1,208,261	+4351.1%	Shares	Defined	2024-05-15
2023-12-31	$114,550	27,145	-36.1%	Shares	Defined	2024-02-14
2023-09-30	$183,508	42,479	-87.5%	Shares	Defined	2023-11-14
2023-06-30	$2,233,514	338,925	-79.2%	Shares	Defined	2023-08-14
2023-03-31	$11,075,438	1,631,140	+471.1%	Shares	Defined	2023-05-12
2022-12-31	$2,110,663	285,611	-17.9%	Shares	Defined	2023-02-10
2022-09-30	$3,437,496	347,925	-27.3%	Shares	Defined	2022-11-14
2022-06-30	$5,217,925	478,709	+54.0%	Shares	Defined	2022-08-12
2022-03-31	$3,515,483	310,830	-19.9%	Shares	Defined	2022-05-16
2021-12-31	$6,088,502	388,050	+26.1%	Shares	Defined	2022-02-08
2021-09-30	$5,275,278	307,776	+10.7%	Shares	Defined	2021-11-15
2021-06-30 ALXN	—	1,429,070	+51.6%	Shares	Defined	2021-09-13
2021-06-30	$5,981,131	278,063	+10.1%	Shares	Defined	2021-09-13
2021-03-31 ALXN	—	942,830	-47.9%	Shares	Defined	2021-05-14
2021-03-31	$3,792,728	252,512	+15.3%	Shares	Defined	2021-05-14
2020-12-31 ALXN	—	1,809,758	-8.8%	Shares	Defined	2021-02-10
2020-12-31 ALXN	—	23,300	0.0%	Put	Defined	2021-02-10
2020-12-31	$2,877,172	218,963	-24.7%	Shares	Defined	2021-02-10
2020-09-30 ALXN	—	1,985,370	+2.7%	Shares	Defined	2020-11-13
2020-09-30 ALXN	—	23,300	-7.9%	Put	Defined	2020-11-13
2020-09-30	$2,808,816	290,768	+19.5%	Shares	Defined	2020-11-13
2020-06-30 ALXN	—	1,932,445	+7.5%	Shares	Defined	2020-08-14
2020-06-30 ALXN	—	25,300	-44.2%	Put	Defined	2020-08-14
2020-06-30	$2,784,505	243,401	+3.6%	Shares	Defined	2020-08-14
2020-03-31 ALXN	—	20,000	—	Call	Defined	2020-05-15
2020-03-31 ALXN	—	1,798,448	—	Shares	Defined	2020-05-15
2020-03-31 ALXN	—	45,300	—	Put	Defined	2020-05-15
2020-03-31	$2,434,174	234,959	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.